Ahngook Pharmaceutical, CHA Biotech and Alvogen participated in the main bidding of DreamPharma acquisition

Published: 2014-06-27 11:02:56

Updated: 2014-06-27 11:02:56

It was identified that Ahngook Pharmaceutical, CHA Biotech and Alvogen participated in the main bidding of DreamPharma acquisition which was closed on June 25.

Dream Pharma is a subsidiary of Hanwha Group, of which Hanwha holds 100% of the shares. It recorded sales of 93 billion won, business profit of 12.8 billion won, and net profit of 27.6 billion won.

Since the announcement of sale, massi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.